Skandinaviska Enskilda Banken (SEB)’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,041	Closed	-$970K	–	990
2023 Q1	$970K	Sell	9,041 -389	-4%	-$41.7K	0.01%	693
2022 Q4	$1.04M	Buy	+9,430	New	+$1.04M	0.01%	661